The collaborative abilities of AI solutions in the medical field are gaining attention, particularly in critical areas such as the early detection of lung cancer. AI is enhancing efficiency and accuracy by supporting medical professionals. These technological advancements are not only serving as auxiliary tools but are also reshaping the entire medical landscape.

Last month, the European Journal of Cancer discussed the first-reader performance of the AI-based lung cancer screening solution, AVIEW LCS. This research paper was developed using data from the European lung cancer screening project, 4-IN-THE-LUNG-RUN (4ITLR), in collaboration with the iDNA team. The study indicated that AVIEW LCS has a significantly lower probability than human radiologists of missing nodules larger than 100mm³, reinforcing the potential of AI to act as a first-reader in lung cancer screenings.

Europe is considered a leading region for pioneering the integration of AI in healthcare, having recently adopted AI as a key component for early lung cancer diagnosis. European countries are swiftly establishing an unprecedented medical paradigm by broadening screening strategies and thus enhancing AI's role in lung cancer detection.

Germany, having achieved notable results in its pilot project (HANSE), has gained attention by recommending mandatory AI diagnostic tools for initial lung screening. Amidst this, Coreline Soft has been demonstrating its competitive edge through successful lung cancer screening projects in Germany (HANSE), Italy (RISP), and five other European countries (iDNA).

In February, Coreline Soft will participate in numerous global exhibitions and conferences across Europe and North America to promote AVIEW LCS, which significantly improves screening efficiency and accuracy. Their strategic approach will include consulting and product-specific promotions. Key exhibition dates are as follows:

• Global AI Conference RCR (London, UK) - February 3-4
• 47th NJH Pulmonary & Allergy Update (Keystone, CO) - February 5-8
• 15th Annual Ottawa Radiology Review Course (Ottawa, Canada) - February 23-28
• Australian Lung Cancer Conference (ALCC) 2025 (Adelaide, Australia) - February 19-21
• ECR 2025 (Vienna, Austria) - February 26-March 2

Among these, ALCC is Australia's largest multidisciplinary lung cancer conference, drawing significant researchers, clinicians, and policymakers to share updates and issues on lung cancer diagnosis, treatment, and prevention. Given its timing ahead of Australia's national lung cancer screening project launch in July, discussions will focus on global lung cancer screening practices and the efficacy of AI-based interpretation.

Yeon Choul-woong 다른기사 보기